Stelios Kasikis

Pediatrics
450 Clarkson Ave
Brooklyn, NY 11203

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD.

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD.

Journal: Blood advances
Published: January 16, 2024

Case 1: Fever in a 40-day-old Infant.

Case 1: Fever in a 40-day-old Infant.

Journal: Pediatrics in review
Published: November 30, 2023

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis.

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis.

Journal: Blood advances
Published: November 01, 2023

A Day 14 Endpoint for Acute GVHD Clinical Trials.

A Day 14 Endpoint for Acute GVHD Clinical Trials.

Journal: Transplantation and cellular therapy
Published: October 03, 2023

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease.

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease.

Journal: Blood advances
Published: January 27, 2023

Effective treatment of low-risk acute GVHD with itacitinib monotherapy.

Effective treatment of low-risk acute GVHD with itacitinib monotherapy.

Journal: Blood
Published: June 16, 2022

Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers.

Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers.

Journal: Bone marrow transplantation
Published: May 18, 2021

Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.

Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.

Journal: Transplantation and cellular therapy
Published: April 24, 2021

Current and Emerging Targeted Therapies for Acute Graft-Versus-Host Disease.

Current and Emerging Targeted Therapies for Acute Graft-Versus-Host Disease.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: November 17, 2020

Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin.

Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin.

Journal: Blood advances
Published: September 10, 2020

The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease.

The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease.

Journal: Blood advances
Published: August 02, 2019
Showing 1-11 of 11

Last Updated: 09/26/2026